Immunological markers of rheumatoid arthritis

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Rheumatoid arthritis (RA) is the most common connective tissue disease of autoimmune origin. The disease is characterized by chronic inflammation leading to bone erosions and organ involvement. RA is a progressive disease. It affects the quality of life, leading to disability and death mainly due to premature cardiovascular disease. Early diagnosis and appropriate treatment are essential for prognosis and quality of life improvement.In 2010 the American College of Rheumatology (ACR) and The European League Against Rheumatism (EULAR) established new RA classification criteria. Besides clinical symptoms it includes two immunologic criteria: rheumatoid factor (RF) and anti-citrullinated protein antibodies (anti-CCP antibodies). RF is the first well-known RA immunologic marker. It is observed in 80-85% of patients with RA. Elevated serum level of RF has been associated with increased disease activity, radiographic progression, and the presence of extraarticular manifestations. The sensitivity of RF is 50-90%, and specificity is 50-95%. Anti-CCP antibodies appear to be a more specific marker than RF. They are often present at the very beginning of the disease, or even years before the first symptoms. The prognostic value of anti-CCP antibodies is well established. High serum level of anti-CCP correlates with poor prognosis and early erosions of the joints. The sensitivity of anti-CCP2 is 48-80%, and specificity is 96-98%.New immunologic markers include anti-carbamylated protein antibodies (anti-CarP) and antibodies against heterogeneous nuclear ribonucleoproteins (anti-hnRNP A2/B1, RA33). Scientists aim to identify a highly sensitive and specific biomarker of the disease that not only has diagnostic and prognostic value but also may predict the response to treatment.

Authors and Affiliations

Agnieszka Matuszewska, Marta Madej, Piotr Wiland

Keywords

Related Articles

Epigenetic determinants in rheumatoid arthritis: the influence of DNA methylation and histone modifications

Epigenetics is a field of science which describes external and environmental modifications to DNA without altering their primary sequences of nucleotides. Contrary to genetic changes, epigenetic modifications are reversi...

Fungi of the genus Malassezia as opportunists of humans and animals

Yeasts from the genus Malassezia are common commensals and pathogens found in humans and animals, and are responsible for tinea cases. Due to their specific cell structure, they may be resistant to environmental stresses...

Powstawanie, metabolizm i ewolucja płytek krwi

Płytki to najmniejsze, pozbawione jądra komórki krwi, które zawierają typowe organelle komórkowe, w tym mitochondria, dzięki czemu wykazują aktywny metabolizm. Płytki mają wysoce zorganizowany cytoszkielet, swoiste ziarn...

Znaczenie zewnątrzkomórkowej alfa-synukleiny w molekularnych mechanizmach śmierci komórek

Niedawne badania wykazały, że zwiększone uwalnianie, oligomeryzacja i toksyczność alfa- synukleiny (ASN) leży u podstaw wielu chorób neurodegeneracyjnych, w tym choroby Parkinsona, czy Alzheimera oraz innych, ogólnie okr...

Ibudilast: nieselektywny inhibitor fosfodiesterazy w chorobach ośrodkowego układu nerwowego

Ibudilast (IBD) jest niewybiórczym inhibitorem fosfodiesterazy (PDE) typu 3, 4, 10, 11, stosowanym głównie jako lek bronchodilatacyjny w leczeniu chorych z astmą. PDE uczestnicząc w metabolizmie cyklicznych nukleotydów,...

Download PDF file
  • EP ID EP220745
  • DOI -
  • Views 149
  • Downloads 0

How To Cite

Agnieszka Matuszewska, Marta Madej, Piotr Wiland (2016). Immunological markers of rheumatoid arthritis. Advances in Hygiene and Experimental Medicine, 70(), 251-257. https://europub.co.uk/articles/-A-220745